Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News

Abnormal Lab Values: When Testing May Be Unnecessary

Lipase, ferritin, and tumor markers require contextual interpretation, as isolated elevations commonly reflect nonpathologic or secondary causes.

Dogs May Trigger Asthma Attacks in Kids

Continuous exposure to dogs in children with asthma is associated with a risk for asthma exacerbations but does not increase the risk for moderate-to-severe asthma.

EU Panel Expands Options in Relapsed Childhood Leukemia

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

SCS Closures in Ontario Spark Harm Reduction Concerns

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

Two EMA Moves Broaden Options in Hemophilia, Iron Deficiency

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

Zoster Vaccine Uptake Low in Rheumatic Disease in the US

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Todays Updates

Do Anatomy Atlases Reflect Social Inequalities?

Historical anatomical illustrations reflect social inequality and may require an ethical context to guide their continued use in clinical education and surgical reference.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

New data highlight the activity and safety of MRD-guided preemptive azacitidine in patients with myelodysplastic neoplasms or AML who develop MRD positivity.

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers examine overall response rates of a HER3-targeting antibody-drug conjugate in pretreated patients with non-small cell lung cancer.

Latest News

Lipase, ferritin, and tumor markers require contextual interpretation, as isolated elevations commonly reflect nonpathologic or secondary causes.

Continuous exposure to dogs in children with asthma is associated with a risk for asthma exacerbations but does not increase the risk for moderate-to-severe asthma.

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

News All Time

Tips on Using Biologics for Psoriasis in Context of HIV

Research on best options is sparse, but biologics can still be helpful for HIV-positive patients with psoriasis.

Markers May Predict Response to Cockroach Allergen Challenge

The wheal size on a skin prick test and interleukin-10 T-cell responses may predict which sensitized children with asthma will have a response to cockroach nasal challenge.

EU Backs New Oral Option in Psoriatic Arthritis

The European Medicines Agency has endorsed expanded use of Sotyktu for psoriatic arthritis, recommending approval after clinical trials showed improvement in joint symptoms.

What We Thought We Knew About the Thymus May Be Wrong

The seemingly unassuming organ has become an emerging target for healthspan, longevity, and precision oncology.

Anifrolumab Shows Promise in Real-World Lupus Care

Anifrolumab treatment is linked to improved disease activity and reduced steroid use and has an acceptable safety profile in routine care of patients with systemic lupus erythematosus.

The Death of the Medical Fax Is Foretold — Again

Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy.

Rare Immune Disorder Drug Wins EU Panel Support

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.

Food-Allergic Adults May Shun Nonallergenic Items

Because of fear of allergic reactions, some patients need psychological counseling and dietary support for a more positive attitude toward food.

Upadacitinib Significantly Improves Vitiligo vs Placebo

The JAK1 inhibitor in development for treating nonsegmental vitiligo was superior to placebo on investigator ratings in two phase 3 trials.

Roflumilast Promising for AD in Children Down to Age 3 Mos

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.

Adrenal Crisis: Rare, Deadly, Preventable — Here’s How

Adrenal crisis remains rare but life-threatening. Better patient, family, and clinician education could help prevent deaths.

Psychosocial Factors May Improve ED Suicide Risk Prediction

Augmentation of data-based risk models with psychosocial factors obtained from clinical notes may improve the prediction of suicide attempts in patients with suicidal ideation, a study shows.

Mar 27 2026 This Week in Cardiology

Early aortic valve replacement in aortic stenosis, left atrial appendage occlusion in JAMA Cardiology, and a big preview of the upcoming American College of Cardiology meeting are the topics John Mandrola, MD, discusses in this week’s podcast.

South Carolina Could Declare Measles Outbreak Over by April 26, Health Official Says

South Carolina could declare its ongoing measles ⁠outbreak over by April 26 if no additional infections are reported, the state's ⁠top epidemiologist said during a briefing...

EU Chemicals Agency Backs Ban on PFAS 'Forever Chemicals'

The European Chemicals Agency on Thursday recommended a broad EU-wide ban on PFAS, or "forever chemicals," with some ⁠exemptions.

Allergic Rhinitis May Worsen Asthma Risk in CRS

Individuals with chronic rhinosinusitis face an elevated risk of developing new-onset asthma and subsequent exacerbations, and concurrent allergic rhinitis increases the risk.

Recommended News For You

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

AI is equally capable of reading breast cancer scans as human radiologists.

A new way to measure suicide risk?

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

Recommended Articles For You

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025 

A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer 

Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments 

The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Getting More Done With Less Blood.

2.

A study suggests that you should disregard the "pack-years" when determining your eligibility for lung cancer screening.

3.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

4.

Fear of hair loss might cause some to reject cancer treatment

5.

A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.

1.

Unlocking the Unknown: A Comprehensive Guide to Stage 4 Vulvar Cancer

2.

Anemia Symptoms: What You Need to Know 

3.

Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools

4.

Octreotide's Efficacy in Reducing Transfusion Requirements in Angiodysplasia Bleeding

5.

Unveiling the Hidden Benefits of Lymphedema Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I

4.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

5.

Navigating the Complexities of Ph Negative ALL - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot